These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39237659)

  • 1. Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport.
    Tu L; Wang J; Sun Y; Wan Y
    AAPS PharmSciTech; 2024 Sep; 25(7):206. PubMed ID: 39237659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Hydroxyethyl Starch Luteolin Nanocrystals for Effective Anti-Hyperuricemia Effect in Mice Model.
    Luo H; Wang X; Fang M; Yu H; Gui L; Wu Z; Sheng J; Li F
    Int J Nanomedicine; 2024; 19():5139-5156. PubMed ID: 38859954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Oral Bioavailability of Luteolin Nanocrystals by Surface Modification of Sodium Dodecyl Sulfate.
    Liu J; Sun Y; Cheng M; Liu Q; Liu W; Gao C; Feng J; Jin Y; Tu L
    AAPS PharmSciTech; 2021 Apr; 22(3):133. PubMed ID: 33855636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.
    Zheng B; Pan F; Shi M; He C; He B; Wang R; Ren G; Yang S; Zhang S
    Int J Nanomedicine; 2024; 19():5273-5295. PubMed ID: 38859952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.
    Tang TT; Hu XB; Liao DH; Liu XY; Xiang DX
    Int J Nanomedicine; 2013; 8():4415-26. PubMed ID: 24277986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, optimization and evaluation of long chain nanolipid carrier for hepatic delivery of silymarin through lymphatic transport pathway.
    Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
    Int J Pharm; 2015 May; 485(1-2):108-21. PubMed ID: 25735668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied.
    Ye JY; Chen ZY; Huang CL; Huang B; Zheng YR; Zhang YF; Lu BY; He L; Liu CS; Long XY
    Int J Nanomedicine; 2020; 15():6503-6518. PubMed ID: 32922013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability.
    Yin J; Xiang C; Wang P; Yin Y; Hou Y
    Int J Nanomedicine; 2017; 12():2923-2931. PubMed ID: 28435268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of Fine Puerarin Nanocrystals by Box-Behnken Design to Enhance Intestinal Absorption.
    Cheng M; Yuan F; Liu J; Liu W; Feng J; Jin Y; Tu L
    AAPS PharmSciTech; 2020 Feb; 21(3):90. PubMed ID: 32060654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of Luteolin Loaded Zein-Caseinate Nanoparticles and its Bioavailability Enhancement in Rats.
    Xu QT; Zhang WX; Xu HX; Zhang QF
    J Pharm Sci; 2023 Dec; 112(12):3056-3066. PubMed ID: 37356712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.
    Elsheikh MA; Elnaggar YSR; Otify DY; Abdallah OY
    Pharm Res; 2018 Jan; 35(1):18. PubMed ID: 29305670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paeonol nanoemulsion for enhanced oral bioavailability: optimization and mechanism.
    Chen S; Zhang J; Wu L; Wu H; Dai M
    Nanomedicine (Lond); 2018 Feb; 13(3):269-282. PubMed ID: 29338580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoprotective Effects of Bioflavonoid Luteolin Using Self-Nanoemulsifying Drug Delivery System.
    Shakeel F; Alamer MM; Alam P; Alshetaili A; Haq N; Alanazi FK; Alshehri S; Ghoneim MM; Alsarra IA
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 16. The Recent Development of Luteolin-loaded Nanocarrier in Targeting Cancer.
    Kar B; Rout SR; Halder J; Mahanty R; Mishra A; Saha I; Rajwar TK; Dash P; Das C; Pradhan D; Rai VK; Ghosh G; Rath G
    Curr Pharm Des; 2024; 30(27):2129-2141. PubMed ID: 38963114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced bioavailability and antihypertensive activity of nisoldipine loaded nanoemulsion: optimization, cytotoxicity and uptake across Caco-2 cell line, pharmacokinetic and pharmacodynamic studies.
    Mundada VP; Patel MH; Mundada PK; Sawant KK
    Drug Dev Ind Pharm; 2020 Mar; 46(3):376-387. PubMed ID: 32031412
    [No Abstract]   [Full Text] [Related]  

  • 18. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats.
    Sun M; Zhai X; Xue K; Hu L; Yang X; Li G; Si L
    Eur J Pharm Sci; 2011 Jun; 43(3):132-40. PubMed ID: 21530655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
    Lind ML; Jacobsen J; Holm R; Müllertz A
    Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation optimization and the absorption mechanisms of nanoemulsion in improving baicalin oral exposure.
    Wu L; Bi Y; Wu H
    Drug Dev Ind Pharm; 2018 Feb; 44(2):266-275. PubMed ID: 29022400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.